1. Home
  2. HRMY vs RAMP Comparison

HRMY vs RAMP Comparison

Compare HRMY & RAMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.06

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo LiveRamp Holdings Inc.

RAMP

LiveRamp Holdings Inc.

HOLD

Current Price

$23.14

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
RAMP
Founded
2017
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.8B
IPO Year
2020
1987

Fundamental Metrics

Financial Performance
Metric
HRMY
RAMP
Price
$37.06
$23.14
Analyst Decision
Strong Buy
Buy
Analyst Count
8
6
Target Price
$49.75
$37.67
AVG Volume (30 Days)
612.6K
601.3K
Earning Date
02-24-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
50.44
86614.23
EPS
3.17
1.05
Revenue
$825,944,000.00
$795,572,000.00
Revenue This Year
$23.34
$11.07
Revenue Next Year
$16.28
$9.11
P/E Ratio
$11.49
$21.40
Revenue Growth
21.13
9.18
52 Week Low
$25.52
$21.71
52 Week High
$40.87
$36.08

Technical Indicators

Market Signals
Indicator
HRMY
RAMP
Relative Strength Index (RSI) 48.18 38.17
Support Level $36.27 $21.71
Resistance Level $38.04 $24.95
Average True Range (ATR) 1.18 0.90
MACD -0.03 -0.13
Stochastic Oscillator 50.14 44.49

Price Performance

Historical Comparison
HRMY
RAMP

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About RAMP LiveRamp Holdings Inc.

LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.

Share on Social Networks: